Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung
2017
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma
2016
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials
2018
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
2019 Standout
Gastric cancer
2016 Standout
Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
2013
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer
2006
Cushing's syndrome
2015 Standout
Why invest, and what it will take to improve breastfeeding practices?
2016 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer
2012
Colorectal cancer
2013 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
2010 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Oxaliplatin: a review of approved uses
2011
STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue
2014
Fluorescence nanoscopy in cell biology
2017 StandoutNobel
Untying the gordion knot of targeting MET in cancer
2018
Gastric cancer
2020 Standout
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Advanced gastric cancer: Current treatment landscape and future perspectives
2016
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus
2013
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
SEROTONIN IMMUNOREACTIVITY IN CARCINOID TUMOURS DEMONSTRATED BY A MONOCLONAL ANTIBODY
1982 StandoutNobel
Chemotherapy for advanced gastric cancer
2017 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
The natural history of treated Cushing's syndrome
1971
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2006
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
2008
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Update on Metastatic Gastric and Esophageal Cancers
2015
Molecular-targeted first-line therapy for advanced gastric cancer
2016
Breast is Best…But Not Everywhere: Ambivalent Sexism and Attitudes Toward Private and Public Breastfeeding
2009
Tumours of the Lung and the Carcinoid Syndrome
1960
Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer
2017 Standout
Works of Mark Harrison being referenced
Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
2006
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
2014
Prognostic factors for recurrence and survival in anal cancer
2012
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
2014
Antiepidermal growth factor receptor radiosensitizers in rectal cancer
2011
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
2005
CUSHING'S SYNDROME WITH CARCINOMA OF BRONCHUS AND WITH FEATURES SUGGESTING CARCINOID TUMOUR
1957
The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.
2013
Cost-effectiveness of combination chemotherapy (oxaliplatin or irinotecan in combination with 5-FU/FA) compared with 5-FU/FA alone
2001
Social coercion for weaning
1987